Browse our wide selection of products for your research needs
We can offer a discount on bulk orders.
Please contact our sales team for further inquiry.
| Product Name | Doxorubicin-SAA modified lipid nanoparticles-DTPA complex |
| Catalog Number | LNP-137 |
| Size | 10 mg; 20 mg; 50 mg |
| Alias | DOX-SAA@LNP-DTPA; Doxorubicin-serum amyloid A modified lipid nanoparticles-diethylenetriaminepentaacetic acid complex, |
| Appearance | Dispersion |
| Solubility | It can be stably dispersed in aqueous solution to form a colloidal system |
| Description | DOX-SAA@LNP-DTPA is a nanocomposite that integrates drug delivery, targeted transport and imaging functions. The complex uses lipid nanoparticles (LNP)as the core carrier. With its good biocompatibility and degradability, it can efficiently encapsulate doxorubicin, effectively protect the drug activity and reduce the side effects of the drug on normal tissues. |
| Applications | MRI contrast agent |
| Storage | 2-8°C, protected from light |
| Purity | 95%+ |
| Shelf Life | 1 Year |
| Shipping Condition | Low temperature transport |